The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $12.65

Today's change-0.25 -1.94%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $12.65

Today's change-0.25 -1.94%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Meridian Bioscience Inc crosses below 20-day moving average

Meridian Bioscience Inc closed sharply lower Friday, dropping (U.S.)$0.25 or 1.94% to (U.S.)$12.65 and crossing below its 20-day moving average. Over the last five days, shares have lost 0.78% and are down 28.53% for the last year to date. This security has underperformed the S&P 500 by 60.97% during the last year.

Key company metrics

  • Open(U.S.) $12.80
  • Previous close(U.S.) $12.90
  • High(U.S.) $12.90
  • Low(U.S.) $12.50
  • Bid / Ask(U.S.) $9.50 / (U.S.) $15.00
  • YTD % change-28.53%
  • Volume358,892
  • Average volume (10-day)458,751
  • Average volume (1-month)603,607
  • Average volume (3-month)411,575
  • 52-week range(U.S.) $10.75 to (U.S.) $21.49
  • Beta0.98
  • Trailing P/E18.14×
  • P/E 1 year forward19.22×
  • Forward PEG1.13×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield3.95%
  • Trailing EPS(U.S.) $0.70
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX1.57%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue47475151
Total other revenue--------
Total revenue47475151
Gross profit29303334
Total cost of revenue17171818
Total operating expense37383736
Selling / general / administrative16161615
Research & development3443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--10--
Other operating expenses, total--------
Operating income1091415
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1091315
Income after tax6599
Income tax, total3356
Net income6599
Total adjustments to net income--------
Net income before extra. items6599
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6599
Inc. avail. to common incl. extra. items6599
Diluted net income6599
Dilution adjustment------0
Diluted weighted average shares43424242
Diluted EPS excluding extraordinary itemsvalue per share0.150.130.210.21
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.150.140.210.21